Holocene Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215M | Buy |
5,609,531
+304,489
| +6% | +$11.7M | 0.53% | 54 |
|
|
2025
Q1 | $206M | Buy |
5,305,042
+4,792,922
| +936% | +$186M | 0.6% | 47 |
|
|
2024
Q4 | $17.3M | Buy |
512,120
+446,819
| +684% | +$15.1M | 0.06% | 260 |
|
|
2024
Q3 | $2.67M | Sell |
65,301
-5,624,394
| -99% | -$230M | 0.01% | 500 |
|
|
2024
Q2 | $219M | Sell |
5,689,695
-3,029,949
| -35% | -$117M | 0.91% | 20 |
|
|
2024
Q1 | $374M | Buy |
8,719,644
+495,096
| +6% | +$21.2M | 1.37% | 4 |
|
|
2023
Q4 | $305M | Buy |
8,224,548
+3,210,489
| +64% | +$119M | 1.19% | 8 |
|
|
2023
Q3 | $182M | Buy |
5,014,059
+2,096,223
| +72% | +$76M | 0.8% | 30 |
|
|
2023
Q2 | $104M | Buy |
2,917,836
+1,735,217
| +147% | +$61.8M | 0.44% | 75 |
|
|
2023
Q1 | $42.1M | Buy |
+1,182,619
| New | +$42.1M | 0.21% | 142 |
|
|
2022
Q3 | – | Sell |
-200,000
| Closed | -$10.9M | – | 858 |
|
|
2022
Q2 | $10.9M | Buy |
+200,000
| New | +$10.9M | 0.07% | 205 |
|